Magazine | IBA | Protect Enhance and Save lives

Improving the proton therapy journey of cancer centers

When a cancer center decides to add proton therapy to its radiation oncology department, it makes a long-term commitment to therapeutic innovation and high-quality patient care. A question remains essential: how to select the best proton therapy equipment provider, to ensure optimal installation and best-in-class performance throughout the system’s lifecycle?

Does IBA support radiation oncology centers in improving their proton therapy journey?

Selecting the right partner in Proton Therapy

Adding proton therapy to a radiation oncology department is an important long-term investment for cancer centers. In this blog, you will discover some essential points to consider when selecting the right proton therapy partner, as explained by Dr. Arie Dosoretz, radiation oncologist and managing partner for Advocate Radiation Oncology and Southwest Florida Proton in Fort Myers, Florida. As they embark on the installation of the IBA ProteusONE system, their well-informed decision went beyond mere technology. As Dr. Dosoretz highlights, the choice is also motivated by the possibility to build a lasting partnership, aimed at meeting current needs but also ensuring future adaptability and growth.

Moffitt’s Proton Therapy partnership with IBA

In the evolving landscape of cancer treatment, proton therapy stands out as a revolutionary approach, particularly for patients with unique tumor circumstances. Dr. Peter Johnstone, a radiation oncologist at Moffitt Cancer Center in Tampa, Florida, highlights the powerful benefits of partnering with IBA to enhance patient care through innovative proton therapy solutions. This article explores the insights shared by Dr. Johnstone regarding the IBA partnership for today and tomorrow, focusing on the advantages of proton therapy and the collaborative journey ahead.

Pushing the boundaries of Proton Therapy with ProteusONE

In the realm of cancer treatment, the pursuit of innovation is relentless. Proton therapy has emerged as a transformative approach, pushing the boundaries of cancer care. Dr. Michael Kasper is the Medical Director at the Lynn Cancer Institute of Boca Raton Regional Hospital, Baptist Health, South Florida. This blog highlights Dr. Kasper’s insights on the advancements in radiation oncology and in proton therapy, and the significant role of the ProteusONE system in this evolving landscape.

First proton therapy system restoration at Massachusetts General Hospital

The journey of proton therapy for cancer treatment has been transformative, particularly at Massachusetts General Hospital (MGH). The discussion led by Dr. Helen Shih and Dr. Anthony Zietman highlights the advancements in proton therapy at MGH since its initial installation in the 1960s, and the excitement of the first restoration of a proton therapy system. Dr. Shih is the medical director of the Proton Therapy Center, specializing in brain and ocular tumors, while Dr. Zietman, former chief of Radiation Oncology, specializes in genitourinary (GU) oncology and has been using proton therapy since for almost four decades.

Compact Proton Therapy at IEO Milan: Precision, Comfort, and Future-Ready Care

Find out how ProteusONE at IEO Milan combines precision, patient comfort, and future-ready technology to set new standards in cancer care.

Improve the environmental sustainability of cancer care

How can we improve the environmental impact of cancer care in the growing context of climate change and worldwide ecological issues?

The Strategic and Clinical Benefits of Compact Proton Therapy at TMUH

In the heart of Taipei, where every square meter is precious and the demand for advanced healthcare is ever-growing, Taipei Medical University Hospital (TMUH) redefined its approach to cancer care by integrating proton therapy as a core component of its world-class oncology program. At the core of this transformation is ProteusONE, IBA’s compact proton therapy system, selected for its ability to address the unique challenges of urban hospital environments while meeting TMUH’s clinical needs for precision and efficiency.

In this article, we dive into the expert testimonials of five TMUH leaders whose roles span the entire proton therapy ecosystem: from institutional leadership to hands-on patient care. Their combined insights reveal how ProteusONE has overcome spatial and operational constraints, redefined clinical efficiency, enhanced the patient experience, and strengthened TMUH’s institutional strategy in one of Asia’s most densely populated cities.

Cookies policy

Manage your cookie preferences